LH
stock Healthcare Diagnostics & ResearchOverall Mixed · 54%
- Fundamentals Strong
- Trajectory Climbing
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 1 of 5 trend signals bullishRSI 50 — momentum is balanced between buyers and sellers.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $258.92
- +0.47%
- Close
- $258.92
- +0.47%
- Current
- $258.92
- Prev close
- $257.70
- Today
- 490.19K
- 3-mo avg
- 610.70K
Earningscalendar synced from Yahoo 57d ago
- Most recent
- Apr 3082 days ago
- Next expected
- Jul 23in 2 days
Recent earnings dates
- Apr 30 82 days ago
- Feb 17 154 days ago
- Oct 28, 2025 266 days ago
- Jul 24, 2025 362 days ago
Past earnings dates come from LH’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), LH’s fundamentals read as strong overall.
At 22.9x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 1.1% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 6.3% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 10.2% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 4.8% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 1.13, the company carries a moderate, manageable amount of debt.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.42, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 7.2% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 17.5% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $13.1B | $11.9B | $12.2B | $13.0B | $14.0B |
| Net income | $2.4B | $1.3B | $418.0M | $746.0M | $876.5M |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
| Dividend / share | — | $2.16 | $2.88 | $2.88 | $2.88 |
| Total assets | $20.4B | $20.2B | $16.7B | $18.4B | $18.4B |
| Total liabilities | $10.1B | $10.0B | $8.8B | $10.3B | $9.8B |
| Shareholder equity | $10.3B | $10.1B | $7.9B | $8.1B | $8.6B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.3B | $3.3B | $3.5B | $3.6B | $3.5B | $3.5B |
| Net income | $228.0M | $228.0M | $62.0M | $212.8M | $212.8M | $212.8M | $238.1M | $277.8M |
| Diluted EPS | $2.43 | $2.00 | $1.72 | $2.52 | $2.84 | $3.12 | $1.98 | $3.35 |
| Dividend / share | $0.72 | $0.72 | — | $0.72 | $0.72 | $0.72 | $0.72 | $0.72 |
Leadershipsynced from SEC 55d ago
- Schechter Adam H President & CEO · Director
- Schroeder Mark S EVP, Pres Diagnostics & COO
- Caveney Brian J EVP, Pres of ED, CMO & CSO
- Graham Anita Z EVP, CHRO
- Oyegunwa Akinbolade EVP, CIO & CTO
- Summy Amy B. EVP, Chief Marketing Officer
- Van Der Vaart Sandra D EVP, Corporate Affairs
- Vaughn Bryan T EVP, Diagnostics
- Wilkinson Peter J SVP, Chief Accounting Officer
Officers and board are drawn from LH’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- Feb 9 Officer or director change reported in an 8-K
- Dec 15, 2025 Officer or director change reported in an 8-K
- Dec 10, 2025 Officer or director change reported in an 8-K
- Nov 24, 2025 Officer or director change reported in an 8-K
- Oct 28, 2025 −5.8% one-day move
- Jul 24, 2025 +6.9% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $2.88
- 2026 so far
- $1.442 payments
- 2026 projected
- $2.88+0.0% vs 2025
Projection scales LH’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- May 29 $0.72
- Feb 27 $0.72
- Nov 26, 2025 $0.72
- Aug 28, 2025 $0.72
- May 29, 2025 $0.72
- Feb 27, 2025 $0.72
- Nov 26, 2024 $0.72
- Aug 29, 2024 $0.72
- May 24, 2024 $0.72
- Feb 26, 2024 $0.72
- Nov 7, 2023 $0.72
- Aug 7, 2023 $0.72
- May 17, 2023 $0.62
- Feb 22, 2023 $0.62
- Nov 16, 2022 $0.62
- Aug 17, 2022 $0.62
- May 18, 2022 $0.62
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report